Skip to main content

Table 5 Group V, cases diagnosed with other malignant neoplasms

From: Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience

Case no. HER2/neu Primary site Histopathology diagnosis
IHC FISH Result Type FIGO Nuc
1 3+ 3.5 POS Endometrium UnDiff 3 3
2 0 NP NEG Endometrium UnDiff 3 3
3 1+ NP NEG Endometrium UnDiff 3 3
4 NP 1 NEG Endometrium UnDiff 3 3
5 0 NP NEG Ovary MMMT NA NA
6 0 1.54 NEG Endometrium MMMT NA NA
7 0 NP NEG Endometrium MMMT NA NA
8 1+ NP NEG Endometrium MMMT NA NA
9 1+ NP NEG Pelvic Mass MMMT NA NA
10 1+ 1 NEG Endometrium MMMT NA NA
11 1+ NP NEG Ovary MMMT NA NA
12 0 NP NEG Endometrium ESS NA NA
13 0 NP NEG Endometrium ESS NA NA
14 1+ NP NEG Cervix ECAdCA 1 1
15 0 NP NEG Ovary Yolk Sac Tumor NA NA
  1. Bold data signify the positive results
  2. IHC immunohistochemistry score, FISH fluorescence in-situ hybridization HER2/CEP17 ratio, FIGO FIGO grade, Nuc nuclear grade, NP not performed, POS positive, NEG negative, UnDiff undifferentiated carcinoma, ECAdCA endocervical adenocarcinoma, MMMT malignant mixed Müllerian tumor, ESS endometrial stromal sarcoma, NA not applicable